Omosefe Ogbeifun, MD
Endocrinology, Diabetes & Metabolism Physician · Birmingham, AL
Omosefe Ogbeifun, MD is an endocrinology, diabetes & metabolism physician with a practice address in Birmingham, Alabama, and NPI 1770213076, issued on Jun 10, 2022. Check the license (Alabama 50158, as entered in NPPES) on the Alabama Board of Medical Examiners; the Medicare figures below come from public CMS files.
- Name
- Omosefe Ogbeifun
- Credential
- MD
- Primary taxonomy
- Endocrinology, Diabetes & Metabolism Physician 207RE0101X
- License number
- 50158 AL
Self-reported in NPPES; status is on the state search - Practice location
- 1201 11TH Ave S Ste 410, Birmingham, AL 35205
- Phone
- (205) 996-2671
- Enumerated
- Jun 10, 2022
- Record last updated
- Apr 29, 2025
- Medicare enrollment
- Enrolled (PECOS I20250501002255); accepts Medicare assignment
- Entity
- Type 1 · individual
8 nearest endocrinology, diabetes & metabolism physician records → All 92 in Alabama → Look up another NPI →
Also registered at 1201 11TH Ave S Ste 410
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Yoser Al RawiStudent in an Organized Health Care Education/Training Program1689303984
- Caroline Cohen, PHD, RDRegistered Dietitian1992328546
- Kaylee Crockett, PHDClinical Psychologist1740720853
- Andrea DialAdult Health Nurse Practitioner1003318619
- Matthew Miesch, MDSports Medicine (Family Medicine) Physician1356847057
Verify Omosefe Ogbeifun in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersAlabama Board of Medical Examiners
Search for license 50158Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
89% fewer Medicare Part D claims than the average endocrinology, diabetes & metabolism physician in 2024
294 Medicare Part D claims for 58 beneficiaries, against an average of 2,630 among the 8,223 providers of this specialty who prescribed in Part D. Brand-name drugs were 13% of claims.
Most prescribed
- Atorvastatin Calcium29 claims
- Amlodipine Besylate26 claims
- Losartan Potassium15 claims
- Pantoprazole Sodium14 claims
- Hydrochlorothiazide11 claims
- Jardiance11 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Bills Medicare through one group practice
- University OF Alabama Health Services Foundation, PCBirmingham, AL
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Omosefe Ogbeifun among 92 endocrinology, diabetes & metabolism physician records in Alabama
Omosefe Ogbeifun, MD is one of 92 endocrinology, diabetes & metabolism physician records with a practice address in Alabama. 90% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2022, is newer than 99% of them.
- NPI issued2022 · 99% of these records are older, 0% newer
- In a Medicare fileYes · 90% of these records are
- In the CMS Doctors and Clinicians fileYes · 74% of these records are
- Graduated2008 · median 2001 among the 68 with a school on file
- Record last updated2025 · 52% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RE0101X and a Alabama practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Endocrinology, Diabetes & Metabolism Physician providers in Alabama
There are 92 endocrinology, diabetes & metabolism physician records in Alabama.
All 92 in Alabama → Every provider in Birmingham → Endocrinology, Diabetes & Metabolism Physician nationwide →
The 8 endocrinology, diabetes & metabolism physician records with the nearest ZIP codes
- William Moore, MDBirmingham, AL 352051457794570
- Maria Prelipcean, M.D.Birmingham, AL 352051457326779
- Jennifer Elizabeth Sohn, MDBirmingham, AL 352051467665646
- Farah Ghori-Javed, M.DBirmingham, AL 352091073807871
- Edison Goncalves, MDBirmingham, AL 352091457309593
- Jorge Pino, M.D.Birmingham, AL 352091013072461
- Ralph Teague, M.D.Birmingham, AL 352091225099385
- David Bell, M.D.Irondale, AL 352101730230988
Common questions
What is Omosefe Ogbeifun, MD's NPI number?
Omosefe Ogbeifun, MD's National Provider Identifier (NPI) is 1770213076, issued on Jun 10, 2022. An NPI identifies a provider in billing; it is not a license.
Where is Omosefe Ogbeifun, MD located?
The NPPES record lists a practice address at 1201 11TH Ave S Ste 410, Birmingham, AL, 35205. Phone: (205) 996-2671. Providers update this record themselves, so call before visiting.
How can I verify Omosefe Ogbeifun, MD's license?
NPPES lists Alabama license number 50158, as entered by the provider. Search the Alabama Board of Medical Examiners at https://www.albme.gov/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Omosefe Ogbeifun, MD prescribe under Medicare Part D?
In 2024, Omosefe Ogbeifun, MD had 294 Medicare Part D claims for 58 beneficiaries; the average among endocrinology, diabetes & metabolism physician prescribers was 2,630. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.